Treatment of proximal deep-vein thrombosis with
            the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral
            direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein
            thrombosis) study

Goldhaber, Samuel Z; Haas, Sylvia; Huisman, Menno V; Hull, Russel D; Kakkar, Ajay K; Misselwitz, Frank; Schellong, Sebastian; Agnelli, Giancarlo; Gallus, Alexander Stephen

oai:dspace.flinders.edu.au:2328/10269

Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study

Authors: Samuel Z Goldhaber
Sylvia Haas
Menno V Huisman
Russel D Hull
Ajay K Kakkar
Frank Misselwitz
Sebastian Schellong
Giancarlo Agnelli
Alexander Stephen Gallus
Publication date: 1 January 2007
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Doi

Abstract

Abstract is not available.

Similar works

Full text

Flinders Academic Commons

oai:dspace.flinders.edu.au:232...

Last time updated on 30/08/2013

This paper was published in Flinders Academic Commons.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.